Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Worldwide Adenosine Triphosphate Swab Test Industry to 2027 - Growing Spending on Patient Safety and Care Presents Opportunities

      Research and Markets Logo

      News provided by

      Research and Markets

      Jun 02, 2021, 06:30 ET

      Share this article

      Share this article


      DUBLIN, June 2, 2021 /PRNewswire/ -- The "Adenosine Triphosphate Swab Test Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type and Application" report has been added to ResearchAndMarkets.com's offering.

      The adenosine triphosphate (ATP) swab test market was valued at US$ 198.21 million in 2019 and is projected to reach US$ 369.71 million by 2027; it is expected to grow at a CAGR of 8.10% from 2019 to 2027. The growth of the market is mainly attributed to the rising prevalence of healthcare associated infections (HAIs) and increasing emphasis on food safety. However, limitations of ATP swab tests limit the market growth.

      HAIs, also known as nosocomial infections, are acquired while receiving treatment or therapies in healthcare facilities. These infections are related to surgical procedures and medical instruments used during procedures. HAIs are responsible for morbidity and mortality of significant number of patients in the world. According to a study published by the Centers for Disease Control and Prevention (CDC) in 2019, 1 in 31 hospital patients is estimated to have some kind of HAI. In addition, according to estimates by The European Centre for Disease Prevention and Control in 2019, ~4.1 million patients across Europe suffer due to HAIs every year. Furthermore, according to study published in the Journal of Antimicrobial Resistance & Infection Control in 2019, the incidence rate of HAIs in China was 3.62 per 1,000 patient days.

      Out of this rate of incidence, respiratory tract infection accounted for 43.80% of infections while bloodstream and urinary tract infections accounted for 15.74% and 12.69% of infections, respectively. The hospital visits and patient pool is likely to increase in the coming years due to the mounting prevalence of chronic conditions and outbreaks of infectious diseases. HAIs also contribute to this increasing population of patients. For instance, the World Health Organization (WHO) estimates published in 2019, 421 million hospitalizations are conducted worldwide every year. Of these, 42.7 million patients suffer from adverse reactions or infections acquired at healthcare settings. Also, according to the same estimates, 50.0% of these adverse events are preventable in developed countries. Thus, such rising prevalence of HAIs is one of the prominent factors driving the demand for ATP swab tests.

      The implementation of safety measures to prevent the spread of COVID-19 is driving the adoption of adenosine triphosphate (ATP) swabs. Moreover, the major shift in focus toward microbial safety amid the pandemic is offering lucrative opportunities for the growth of the market players.

      Based on type, the adenosine triphosphate (ATP) swab test market is segmented into free ATP test and microbial ATP test. The free ATP test segment held a larger share of the market in 2019; however, the microbial ATP test segment is estimated to register a higher CAGR during the forecast period. The rising number focus on food safety and sterilization on microbial level is estimated to offer lucrative opportunity for the microbial ATP test segment growth.

      The adenosine triphosphate (ATP) swab test market, by application, is segmented into pharmaceutical and biotechnology companies, food and beverage, hospitals and diagnostics laboratories, and academic and research institutions. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2019, and it is estimated to register the highest CAGR during the forecast period.

      The World Health Organization (WHO), Food and Drug Administration (FDA), National Health Service (NHS), and Centers for Disease Control and Prevention (CDC) are among the major primary and secondary sources referred to while preparing this report.

      Key Topics Covered:

      1. Introduction

      2. Adenosine Triphosphate (ATP) Swab Test Market- Key Takeaways

      3. Research Methodology
      3.1 Coverage
      3.2 Secondary Research
      3.3 Primary Research

      4. Global Adenosine Triphosphate (ATP) Swab Test Market - Market Landscape
      4.1 Overview
      4.2 PEST Analysis
      4.2.1 North America PEST Analysis
      4.2.2 Europe PEST Analysis
      4.2.3 Asia Pacific - PEST Analysis
      4.2.4 Middle East & Africa- PEST Analysis
      4.2.5 South & Central America - PEST Analysis
      4.3 Expert Opinion

      5. Adenosine Triphosphate (ATP) Swab Test Market - Key Market Dynamics
      5.1 Market Drivers
      5.1.1 Rising Prevalence of Healthcare-Associated Infections (HAI)
      5.1.2 Increasing Emphasis on Food Safety
      5.2 Market Restraint
      5.2.1 Limitations of ATP Swab Tests
      5.3 Market Opportunity
      5.3.1 Growing Spending on Patient Safety and Care
      5.4 Future Trend
      5.4.1 Development of Adenylate (A3) Concentration Based Modern Sterility Monitoring System
      5.5 Impact Analysis

      6. Adenosine Triphosphate (ATP) Swab Test Market - Global Analysis
      6.1 Global Adenosine Triphosphate (ATP) Swab Test Market Revenue Forecast and Analysis
      6.2 Global Adenosine Triphosphate (ATP) Swab Test Market, By Geography - Forecast and Analysis
      6.3 Market Positioning of Key Players

      7. Adenosine Triphosphate (ATP) Swab Test Market Analysis and Forecasts To 2027 -Type

      8. Adenosine Triphosphate (ATP) Swab Test Market Analysis and Forecasts To 2027 - Application

      9. Adenosine Triphosphate (ATP) Swab Test Analysis and Forecasts To 2027 - Geographical Analysis

      10. Impact Of COVID-19 Pandemic on Global Adenosine Triphosphate (ATP) Swab Test Market
      10.1 North America: Impact Assessment of COVID-19 Pandemic
      10.2 Europe: Impact Assessment Of COVID-19 Pandemic
      10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
      10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
      10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

      11. Adenosine Triphosphate (ATP) Swab Test Market -Industry Landscape
      11.1 Overview
      11.2 Recent Growth Strategies in The Adenosine Triphosphate (ATP) Swab Test Market

      12. Company Profiles
      12.1 3M
      12.1.1 Key Facts
      12.1.2 Business Description
      12.1.3 Products and Services
      12.1.4 Financial Overview
      12.1.5 SWOT Analysis
      12.1.6 Key Developments
      12.2 Hygiena, LLC
      12.2.1 Key Facts
      12.2.2 Business Description
      12.2.3 Products and Services
      12.2.4 Financial Overview
      12.2.5 SWOT Analysis
      12.2.6 Key Developments
      12.3 Charm Sciences
      12.3.1 Key Facts
      12.3.2 Business Description
      12.3.3 Products and Services
      12.3.4 Financial Overview
      12.3.5 SWOT Analysis
      12.3.6 Key Developments
      12.4 Kikkoman Biochemifa Co
      12.4.1 Key Facts
      12.4.2 Business Description
      12.4.3 Products and Services
      12.4.4 Financial Overview
      12.4.5 SWOT Analysis
      12.4.6 Key Developments
      12.5 Neogen Corporation
      12.5.1 Key Facts
      12.5.2 Business Description
      12.5.3 Products and Services
      12.5.4 Financial Overview
      12.5.5 SWOT Analysis
      12.5.6 Key Developments
      12.6 Ecolab
      12.6.1 Key Facts
      12.6.2 Business Description
      12.6.3 Products and Services
      12.6.4 Financial Overview
      12.6.5 SWOT Analysis
      12.6.6 Key Developments
      12.7 Ruhof Healthcare Corporation
      12.7.1 Key Facts
      12.7.2 Business Description
      12.7.3 Products and Services
      12.7.4 Financial Overview
      12.7.5 SWOT Analysis
      12.7.6 Key Developments
      12.8 LuminUltra Technologies Ltd.
      12.8.1 Key Facts
      12.8.2 Business Description
      12.8.3 Products and Services
      12.8.4 Financial Overview
      12.8.5 SWOT Analysis
      12.8.6 Key Developments
      12.9 MERCK KGaA
      12.9.1 Key Facts
      12.9.2 Business Description
      12.9.3 Products and Services
      12.9.4 Financial Overview
      12.9.5 SWOT Analysis
      12.9.6 Key Developments
      12.10 Promicol
      12.10.1 Key Facts
      12.10.2 Business Description
      12.10.3 Products and Services
      12.10.4 Financial Overview
      12.10.5 SWOT Analysis
      12.10.6 Key Developments
      12.11 PCE Instruments
      12.11.1 Key Facts
      12.11.2 Business Description
      12.11.3 Products and Services
      12.11.4 Financial Overview
      12.11.5 SWOT Analysis
      12.11.6 Key Developments
      12.12 Promega Corporation
      12.12.1 Key Facts
      12.12.2 Business Description
      12.12.3 Products and Services
      12.12.4 Financial Overview
      12.12.5 SWOT Analysis
      12.12.6 Key Developments
      12.13 CHARLES RIVER LABORATORIES, INC
      12.13.1 Key Facts
      12.13.2 Business Description
      12.13.3 Products and Services
      12.13.4 Financial Overview
      12.13.5 SWOT Analysis
      12.13.6 Key Developments

      13. Appendix

      For more information about this report visit https://www.researchandmarkets.com/r/v5dchj


      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]   

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1904
      Fax (outside U.S.): +353-1-481-1716

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.